# FDG (Fluorodeoxyglucose) Findings After COVID-19 Vaccination

> **NCT05270967** · — · COMPLETED · sponsor: **Kocaeli University** · enrollment: 129 (actual)

## Conditions studied

- Vaccine Reaction
- Oncology

## Interventions

- **DIAGNOSTIC_TEST:** F-18 FDG PET/CT imaging
- **BIOLOGICAL:** Pfizer/biontech mRNA vaccine

## Key facts

- **NCT ID:** NCT05270967
- **Lead sponsor:** Kocaeli University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-29
- **Primary completion:** 2022-01-10
- **Final completion:** 2022-01-10
- **Target enrollment:** 129 (ACTUAL)
- **Last updated:** 2022-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05270967

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05270967, "FDG (Fluorodeoxyglucose) Findings After COVID-19 Vaccination". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05270967. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*